节点文献

儿童非霍奇金淋巴瘤96例临床分析

Clinical Study on Non Hodgkin Lymphoma in Children A Report of 96 Cases

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 熊建萍; 袁华墅; 陈建祥; 王迪进; 万以叶; 周绪堂;

【Author】 Xiong Jianping,Yuan Huashu,Chen Jianxiang,et al(Jiangxi Cancer Hospital,Nanchang,330029)

【机构】 江西省肿瘤医院!南昌市330029; 江西省泰和县人民医院;

【摘要】 回顾分析了1986 年4 月至1998 年4 月住院治疗的96 例儿童非霍奇金淋巴瘤(NHL) 的临床资料。第1 阶段(1986年4 月至1990 年12 月) ,共29 例,采用COP、CHOP、COMP方案治疗6~8 个周期,有中枢神经侵犯者给予MTX、DXM 鞘内注射,每周1 次。第2 阶段(1991 年1 月至1998 年4 月),共67 例,采用CHOP、CHOP加VP16 治疗8~12 个周期,后改用CTX+VCR 巩固治疗共1 .5 a 至2 a,临床Ⅳ期或病理分类恶性度高者常规鞘内注射MTX12 .5 mg/m2( 最大量12 .5 mg) ,DXM5 mg,每周1 次,连续4 次,有中枢神经侵犯者,每周2 次,待脑脊液转阴后改为每周1 次。结果表明,儿童NHL 多见于男性年长儿,高发年龄6~13 岁,Ⅲ、Ⅳ期患儿所占比例高(67.7%) ,易侵犯骨髓(33.3 %) 及中枢神经(13 .5% ),初诊到确诊时间平均为73 d,最长达1a 。第1 阶段疗效为:CR37 .9% ,5a 生存率为20 .0% 。第2 阶段疗效为:CR62.7 % ,5 a 生存率49 .4% 。Ⅰ、Ⅱ与Ⅲ、Ⅳ期的5 a 生存率分别为85 .5% 和9.8 % ,有显著差异(P

【Abstract】 cases of children NHL from April 1986 to April 1998 were retrospectively studied.During first period(from April 1986 to December 1990),29 patients were treated with COP,COPP or COMP regimen for 6~8 cycles,intrathecal chemotherapy with methotrexate and dexamethesone was given once a week on patients with CNS involvement.During secood period(from January 1991 to April 1998),67 patients were treated with CHOP or CHOP plus VP 16 regimen for 8~1O cycles.Then,consolidation chemotherapy with CTX plus VCR was administered for 1.5~2 years,prophylactic intrathecal therapy with MTX.DXM was given routinely once a week in the patient with stage Ⅳ NHL or high grade NHL for four weeks.In the patient with CNS involvment,intrathecal therapy was given twice a week and after tumor cells were negative in CSF,intrathecal therapy was given once a week.NHL in elder male children was more common than others,peak age was between 6~13 years.Patients with stage Ⅲ、Ⅳ NHL accounted for 67.7%.Infiltration of the bone marrow was present in 33.3% patients.CNS involvement occurred in 13.5% patients.The longest time spending from the first visit to confirmed diagnosis was one year,average time was 73 days.Therapeutic results:during first period:CR 37.9%,5 years survival rate was 20.0%.Second period:CR 62.7%,5 years survival rate was 49.4%.5 years survivat rate in stage Ⅰ,Ⅱ and stage Ⅲ,Ⅳ NHL was 85.8%,9.8% respectively,there was significant difference between 5 years survival rate in Ⅰ,Ⅱ stage and Ⅲ,Ⅳ stage NHL(P<0.01).It suggested that the early diagnosis and early treatment will be very important in improving patient′s survival.

  • 【文献出处】 实用癌症杂志 ,THE PRACTICAL JOURNAL OF CANCER , 编辑部邮箱 ,1999年04期
  • 【分类号】R733.1
  • 【被引频次】2
  • 【下载频次】43
节点文献中: 

本文链接的文献网络图示:

本文的引文网络